Progredienzangst ≥5 Jahre nach Krebsdiagnose

• Verfasst von: Koch, Lena [VerfasserIn]
• Verfasst von: Brenner, Hermann [VerfasserIn]
• Verfasst von: Arndt, Volker [VerfasserIn]
• Titel: Progredienzangst ≥5 Jahre nach Krebsdiagnose
• Verf.angabe: Lena Koch-Gallenkamp, Heike Bertram, Andrea Eberle, Bernd Holleczek, Sieglinde Schmid-Höpfner, Annika Waldmann, Sylke R. Zeissig, Hermann Brenner, Volker Arndt
• E-Jahr: 2017
• Jahr: 14. Februar 2017
• Umfang: 5 S.
• Teil: volume:23
• Teil: year:2017
• Teil: number:4
• Teil: pages:295-299
• Teil: extent:5
• Fussnoten: Gesehen am 16.01.2018
• Titel Quelle: Enthalten in: Der Onkologe
• Ort Quelle: Berlin : Springer, 1996
• Jahr Quelle: 2017
• Band/Heft Quelle: 23(2017), 4, Seite 295-299
• ISSN Quelle: 1433-0415
• DOI: doi:10.1007/s00761-017-0188-8
• Datenträger: Online-Ressource
• Sprache: ger
• K10plus-PPN: 1567231543

Abstract

Background and aims: Fears of recurrence or progression of cancer are experienced by many cancer survivors even years after diagnosis and completion of therapy. The identification and recruitment of cancer survivors via cancer registries enables representative studies of fear of progression in long-term cancer survivors. Material and methods: The CAESAR study was funded by the German Cancer Aid and conducted by the German Cancer Research Center in cooperation with 6 population-based German cancer registries. Potential participants were identified by the registries. A questionnaire, including the fear of progression questionnaire by Herschbach et al. to assess fear of progression was mailed to potential participants between 2008 and 2011. Results: More than 7000 persons (mean age 69 years) participated in the study. Even years after diagnosis, the majority of survivors experienced fear of recurrence or progression of the disease. Women and younger survivors were particularly at risk to experience high, potentially dysfunctional levels of fear of progression. Conclusion: Women and younger survivors in particular should be monitored for high levels of fear of progression and offered the support needed in order to avoid or minimize the negative effects on well-being and quality of life.